ARCT
NASDAQ · Biotechnology
Arcturus Therapeutics Holdin
$7.03
-0.44 (-5.89%)
Open$7.43
Previous Close$7.47
Day High$7.50
Day Low$6.95
52W High$24.17
52W Low$5.85
Volume—
Avg Volume495.0K
Market Cap212.32M
P/E Ratio—
EPS$-2.82
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+275.7% upside
Current
$7.03
$7.03
Target
$26.41
$26.41
$16.23
$26.41 avg
$33.18
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 85.14M | 115.72M | 31.39M |
| Net Income | -68,275,055 | -83,522,562 | -5,088,256 |
| Profit Margin | -80.2% | -76.2% | -16.2% |
| EBITDA | -76,008,972 | -98,149,413 | -7,015,778 |
| Free Cash Flow | — | — | -5,929,972 |
| Rev Growth | -26.4% | -26.4% | +5.3% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $213.76 | +2.08% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $330.33 | -0.13% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $130.28 | -0.17% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $429.32 | -1.15% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $641.69 | +1.81% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.86 | -0.15% | 66.6 | 38.43B |